반응식
[CH:1]([O:4][C:5]1[CH:10]=[CH:9][C:8]([CH2:11][C:12]2[C:13]([O:18][C@@H:19]3[O:36][C@H:35]([CH2:37][O:38]C(=O)C)[C@@H:30]([O:31]C(=O)C)[C@H:25]([O:26]C(=O)C)[C@H:20]3[O:21]C(=O)C)=[N:14][NH:15][C:16]=2[CH3:17])=[CH:7][CH:6]=1)([CH3:3])[CH3:2].[OH-].[Na+]>C(O)C>[C@@H:19]1([O:18][C:13]2[C:12]([CH2:11][C:8]3[CH:9]=[CH:10][C:5]([O:4][CH:1]([CH3:2])[CH3:3])=[CH:6][CH:7]=3)=[C:16]([CH3:17])[NH:15][N:14]=2)[O:36][C@H:35]([CH2:37][OH:38])[C@@H:30]([OH:31])[C@H:25]([OH:26])[C@H:20]1[OH:21]참가 물질
4
실험 절차
To a solution of 4-[(4-isopropoxyphenyl)methyl]-5-methyl-3-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyloxy)-1H-pyrazole (61 mg) in ethanol (3 mL) was added 1 mol/L aqueous sodium hydroxide solution (0.53 mL), and the mixture was stirred at room temperature for 2 hours. The solvent was removed under reduced pressure, and the residue was purified by solid phase extraction on ODS (washing solvent: distilled water, eluent: methanol) to give 3-(β-D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-5-methyl-1H-pyrazole (39 mg).
후처리
- customThe solvent was removed under reduced pressure
- distillationthe residue was purified by solid phase extraction on ODS (washing solvent: distilled water, eluent: methanol)
출처 및 근거
- ORD 기록
- ord-d61b8c20f62f4e75b1837978d59d0a91
- 출처 데이터셋
- uspto-grants-2006_08
- 특허 번호
- US07084123B2
연결된 노트
불러오는 중…